TETRALOGIC PHARMACEUTICALS CORP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances

TETRALOGIC PHARMACEUTICALS CORP Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances

TETRALOGIC PHARMACEUTICALS CORP reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $1.69 million for the 12-month period ending 2013-12-31, per its 10-K filed 2015-02-26.

Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2015-02-26

• TETRALOGIC PHARMACEUTICALS CORP fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2013 was $1.69M.